In vitro and in vivo antibacterial activities of CS-940, a new fluoroquinolone, against isolates from patients with respiratory infections

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2582-2585

  Miyazaki, Shuichi ^a   Domon, Haruki ^a   Tateda, Kazuhiro ^a   Ohno, Akira ^a   Ishii, Yoshikazu ^a   Matsumoto, Tetsuya ^a   Furuya, Nobuhiko ^a   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYL 8 DIFLUOROMETHOXY 6 FLUORO 1,4 DIHYDRO 7 (3 METHYL 1 PIPERAZINYL) 4 OXO 3 QUINOLINECARBOXYLIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; CEFDINIR; CIPROFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TOSUFLOXACIN;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CONTROLLED STUDY; FEMALE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030691010     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2582     Document Type: Article

References (14)

1. Biedenbach, D. J., L. D. Sutton, and R. N. Jones. 1995. Antimicrobial activity of CS-940, a new trifluorinated quinolone. Antimicrob. Agents Chemother. 39:2325-2330.
2. Hooper, D. C., and J. S. Wolfson. 1985. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob. Agents Chemother. 28:716-721.
3. Japanese Society for Chemotherapy. 1990. Method for the determination of minimum inhibitory concentration (MIC) of aerobic bacteria by microdilution method. Chemotherapy (Tokyo) 38:102-105.
4. Japanese Society for Chemotherapy. 1993. Method for the determination of minimum inhibitory concentration (MIC) of fastidious bacteria and anaerobic bacteria by microdilution method. Chemotherapy (Tokyo) 41:183-189.
5. Jujimaki, K., T. Nomi, I. Saikawa, M. Inoue, and S. Mitsuhashi. 1988. In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone. Antimicrob. Agents Chemother. 32:827-833.
6. Kojima, T., M. Inoue, and S. Mitsuhashi. 1989. In vitro activity of AT-4140 against clinical bacterial isolates. Antimicrob. Agents Chemother. 33:1980-1988.
7. Masuda, N., Y. Takahashi, M. Otsuki, E. Ibuki, H. Miyoshi, and T. Nishino. 1996. In vitro and in vivo antibacterial activities of CS-940, a new 6-fluoro-8-difluoromethoxy quinolone. Antimicrob. Agents Chemother. 40:1201-1207.
8. Matsumoto, M., K. Kojima, H. Nagano, S. Matsubara, and T. Yokota. 1992. Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation. Antimicrob. Agents Chemother. 36:1715-1719.
9. Miller, L. C., and M. L. Tainter. 1944. Estimation of the ED50 and its error by means of logarithmic probit graph paper. Proc. Soc. Exp. Biol. Med. 57:261-264.
10. Miyazaki, S., T. Nunoya, T. Matsumoto, K. Tateda, and K. Yamaguchi. 1997. New murine model of bronchopneumonia due to cell-bound Haemophilus influenzae. J. Infect. Dis. 175:205-209.
11. Nakashima, M. Personal communications.
12. Sato, K., Y. Matsuura, M. Inoue, T. Une, Y. Osada, H. Ogawa, and S. Mitsuhashi. 1982. In vitro and in vivo activity of DL-8280, a new oxazine derivative. Antimicrob. Agents Chemother. 22:559-564.
13. Tateda, K., K. Takashima, H. Miyazaki, T. Matsumoto, T. Hatori, and K. Yamaguchi. 1996. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. Antimicrob. Agents Chemother. 40:1520-1525.
14. Wise, R., J. M. Andrews, and L. J. Edwards. 1983. In vitro activity of Bay 09867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrob. Agents Chemother. 23:559-564.